Reuters logo
BRIEF-Jiangsu Hengrui Medicine passes FDA approval
September 5, 2017 / 7:06 AM / in 3 months

BRIEF-Jiangsu Hengrui Medicine passes FDA approval

Sept 5(Reuters) - Jiangsu Hengrui Medicine Co Ltd

* Says it received approval for its cisatracurium besilate injection from U.S Food and Drug Administration

* Says the company will be able to sell its cisatracurium besilate injection in the United States after receiving the FDA approval

Source text in Chinese:goo.gl/rm63A9

Further company coverage: (Beijing Headline News)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below